ARCHIVES

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

February 25, 1977

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006